Neisseria meningitidis antigens and compositions

Details for Australian Patent Application No. 2012203235 (hide)

Owner J. Craig Venter Institute, Inc. Novartis Vaccines and Diagnostics, Inc.

Inventors Fraser, Claire; Galeotti, Cesira; Grandi, Guido; Hickey, Erin; Masignani, Vega; Mora, Mariarosa; Petersen, Jeremy; Pizza, Mariagrazia; Rappuoli, Rino; Ratti, Giulio; Scalato, Enzo; Scarselli, Maria; Tettelin, Herve; Venter, J. Craig

Agent FB Rice

Pub. Number AU-A-2012203235

Parent 2009230776

Filing date 31 May 2012

Wipo publication date 21 June 2012

International Classifications

C12N 15/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/095 Medicinal preparations containing antigens or antibodies - Neisseria

C07K 14/22 Peptides having more than 20 amino acids

C07K 16/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

14 June 2012 Complete Application Filed

21 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203235

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203236-An Adhesive Containing Tubular Rock Anchor

2012203234-Heliostat control